HSBC Holdings’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940K Buy
37,777
+19,909
+111% +$471K ﹤0.01% 1902
2025
Q4
$476K Sell
17,868
-19,732
-52% -$430K ﹤0.01% 2344
2025
Q3
$640K Buy
37,600
+1,103
+3% +$15.8K ﹤0.01% 1979
2025
Q2
$461K Buy
+36,497
New +$435K ﹤0.01% 2196
2024
Q1
Sell
-11,749
Closed -$123K 3268
2023
Q4
$123K Hold
11,749
﹤0.01% 2566
2023
Q3
$74.1K Buy
+11,749
New +$86.8K ﹤0.01% 2592
2020
Q3
Sell
-9,593
Closed -$346K 2886
2020
Q2
$346K Buy
+9,593
New +$353K ﹤0.01% 2053

Other funds holding ZYME

HSBC Holdings's ZYME Position: Q1 2026 in Review

HSBC Holdings increased its Zymeworks (ZYME) stake by 111% in Q1 2026, buying an estimated $471K and bringing the position to 37,777 shares worth $940K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

HSBC Holdings first reported a position in ZYME in Q2 2020 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • HSBC Holdings held 37,777 shares of Zymeworks worth $940K as of Q1 2026.
  • HSBC Holdings bought 19,909 Zymeworks shares in Q1 2026, an estimated $471K.
  • Zymeworks made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1902 holding.
  • HSBC Holdings first reported a position in Zymeworks in Q2 2020 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.